These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 22285541)
1. Characterization of human phosphodiesterase 12 and identification of a novel 2'-5' oligoadenylate nuclease - The ectonucleotide pyrophosphatase/phosphodiesterase 1. Poulsen JB; Andersen KR; Kjær KH; Vestergaard AL; Justesen J; Martensen PM Biochimie; 2012 May; 94(5):1098-107. PubMed ID: 22285541 [TBL] [Abstract][Full Text] [Related]
2. Enzyme assays for synthesis and degradation of 2-5As and other 2'-5' oligonucleotides. Poulsen JB; Kjær KH; Justesen J; Martensen PM BMC Biochem; 2015 Jun; 16():15. PubMed ID: 26113370 [TBL] [Abstract][Full Text] [Related]
3. Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity. Asthana A; Gaughan C; Dong B; Weiss SR; Silverman RH mBio; 2021 Aug; 12(4):e0178121. PubMed ID: 34372695 [TBL] [Abstract][Full Text] [Related]
4. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L. Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291 [TBL] [Abstract][Full Text] [Related]
5. Nuclease-resistant composite 2',5'-oligoadenylate-3', 5'-oligonucleotides for the targeted destruction of RNA: 2-5A-iso-antisense. Xiao W; Li G; Player MR; Maitra RK; Waller CF; Silverman RH; Torrence PF J Med Chem; 1998 Apr; 41(9):1531-9. PubMed ID: 9554886 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of 2',5'-oligoadenylate analogs containing an adenine acyclonucleoside and their ability to activate human RNase L. Ueno Y; Ishihara S; Ito Y; Kitade Y Bioorg Med Chem Lett; 2004 Sep; 14(17):4431-4. PubMed ID: 15357966 [TBL] [Abstract][Full Text] [Related]
8. 3'-Fluoro-3'-deoxy analogs of 2-5A 5'-monophosphate: binding to 2-5A-dependent endoribonuclease and susceptibility to (2'-5')phosphodiesterase degradation. Kalinichenko EN; Podkopaeva TL; Kelve M; Saarma M; Mikhailopulo IA Biochem Biophys Res Commun; 1990 Feb; 167(1):20-6. PubMed ID: 2155612 [TBL] [Abstract][Full Text] [Related]
9. A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5' oligoadenylates. Thakur CS; Xu Z; Wang Z; Novince Z; Silverman RH Methods Mol Med; 2005; 116():103-13. PubMed ID: 16000857 [TBL] [Abstract][Full Text] [Related]
10. Identification of 2'-phosphodiesterase, which plays a role in the 2-5A system regulated by interferon. Kubota K; Nakahara K; Ohtsuka T; Yoshida S; Kawaguchi J; Fujita Y; Ozeki Y; Hara A; Yoshimura C; Furukawa H; Haruyama H; Ichikawa K; Yamashita M; Matsuoka T; Iijima Y J Biol Chem; 2004 Sep; 279(36):37832-41. PubMed ID: 15231837 [TBL] [Abstract][Full Text] [Related]
11. 2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome. Frémont M; El Bakkouri K; Vaeyens F; Herst CV; De Meirleir K; Englebienne P Exp Mol Pathol; 2005 Jun; 78(3):239-46. PubMed ID: 15924878 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activities of a phosphorodithioate analog of 2',5'-oligoadenylate. Beigelman L; Matulic-Adamic J; Haeberli P; Usman N; Dong B; Silverman RH; Khamnei S; Torrence PF Nucleic Acids Res; 1995 Oct; 23(19):3989-94. PubMed ID: 7479047 [TBL] [Abstract][Full Text] [Related]
13. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L. Nagaoka K; Kitamura Y; Ueno Y; Kitade Y Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497 [TBL] [Abstract][Full Text] [Related]
14. High yield synthesis, purification and characterisation of the RNase L activators 5'-triphosphate 2'-5'-oligoadenylates. Morin B; Rabah N; Boretto-Soler J; Tolou H; Alvarez K; Canard B Antiviral Res; 2010 Sep; 87(3):345-52. PubMed ID: 20547186 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of 2-5As possessing base-modified adenosines and their activities to human recombinant RNase L. Kitade Y; Tanida Y; Tuboi T; Yoshimura A; Nakanishi M; Yatome C Nucleic Acids Symp Ser; 2000; (44):29-30. PubMed ID: 12903252 [TBL] [Abstract][Full Text] [Related]
16. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate. Kondo Y; Kondo S Methods Mol Biol; 2007; 405():97-112. PubMed ID: 18369820 [TBL] [Abstract][Full Text] [Related]
17. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L. Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293 [TBL] [Abstract][Full Text] [Related]
18. 2'-phosphodiesterase and 2',5'-oligoadenylate synthetase activities in the lowest metazoans, sponge [porifera]. Saby E; Poulsen JB; Justesen J; Kelve M; Uriz MJ Biochimie; 2009; 91(11-12):1531-4. PubMed ID: 19665065 [TBL] [Abstract][Full Text] [Related]
19. Structural basis for 2'-5'-oligoadenylate binding and enzyme activity of a viral RNase L antagonist. Ogden KM; Hu L; Jha BK; Sankaran B; Weiss SR; Silverman RH; Patton JT; Prasad BV J Virol; 2015 Jul; 89(13):6633-45. PubMed ID: 25878106 [TBL] [Abstract][Full Text] [Related]
20. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Player MR; Torrence PF Pharmacol Ther; 1998 May; 78(2):55-113. PubMed ID: 9623881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]